SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009386
Filing Date
2023-03-29
Accepted
2023-03-29 08:30:42
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2378729
2 ex10-15.htm EX-10.15 12312
3 ex10-21.htm EX-10.21 77419
4 ex21-1.htm EX-21.1 4158
5 ex23-1.htm EX-23.1 4042
6 ex31-1.htm EX-31.1 12924
7 ex31-2.htm EX-31.2 12986
8 ex32-1.htm EX-32.1 7124
9 ex32-2.htm EX-32.2 6951
  Complete submission text file 0001493152-23-009386.txt   7447506

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE lixt-20221231.xsd EX-101.SCH 47736
11 XBRL CALCULATION FILE lixt-20221231_cal.xml EX-101.CAL 37321
12 XBRL DEFINITION FILE lixt-20221231_def.xml EX-101.DEF 239248
13 XBRL LABEL FILE lixt-20221231_lab.xml EX-101.LAB 389967
14 XBRL PRESENTATION FILE lixt-20221231_pre.xml EX-101.PRE 299170
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 913221
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39717 | Film No.: 23771857
SIC: 2834 Pharmaceutical Preparations